Fake medicines, products undermine fight against COVID-19

The Transnational Alliance to Combat Illicit Trade (TRACIT) issued a new statement, warning consumers about the risks and growing availability of fake, falsified and substandard medical and healthcare products and medicines, which undermine public health and efforts to stem the COVID-19 pandemic.

“Emergency response measures to protect people from the COVID-19 virus must include the urgent need to protect them from fake, falsified and substandard medical products and medicines,” said TRACIT Director-General Jeffrey Hardy. “Someone wearing a falsified or substandard surgical face mask is not only at risk of exposure, but it creates a false sense of security that can actually accelerate the spread to others.”

Worldwide reports indicate a surge in the availability and type of fraudulent medical products intended to exploit the fears of consumers, which includes illicit offerings of falsified versions of treatments such as Hydroxychloroquine and Azithromycin that will harm or kill already vulnerable patients. 

Joint operations by the World Customs Organization, Europol and Interpol have resulted in a significant increase in seizures of counterfeit and unauthorized face masks and hand sanitizers.

“Expectations are that the availability of fakes and fraudulent products on the Internet will increase dramatically, especially with the closure of retail stores and the imposition of population distancing strategies,” said Hardy. “People must be especially careful with their social media, where outright fraud and advertising of fakes is already a major problem.”

In its statement, TRACIT’s product warning list includes fake, falsified and substandard medical products such as surgical masks, hydro-alcoholic gels, testing kits and thermometers. 

Also listed for increased vigilance are high demand healthcare and consumer products prone to counterfeiting, including cleaning solutions, toilet paper, anti-bacterial wipes, indoor sports equipment, refrigeration appliances, food products and reading materials.

“Once we get past this crisis, we’ll need to double our efforts to prevent counterfeiting and falsification of medical products and medicines,” said Hardy. “This must start with stronger provisions for preventing the availability of illicit products online and stronger measures to keep illicit pharmaceuticals out of the physical supply chain, including postal and express carrier infrastructures.”

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email
Editor

Editor

A team of dedicated journalists whose mission is to advocate for ethics and transparency in the maritime industry.

More Stories from Maritime Fairtrade

Donate to Maritime Fairtrade

Your support helps sustain our extraordinary level of research and publication, enabling millions of readers to learn more about the maritime industry and make informed decisions. Thank you for your support.

This is a secure webpage.
We do not store your credit card information.

The best maritime news and insights delivered to you.

Here's what you can expect from us:

  • News & key insights covering the maritime industry
  • Expert analysis and opinions on maritime corruption and more
  • Exclusive interviews